Artemis Medicare (Small Cap - Potential Multibagger) Share Target 2026, 2027 To 2035
|
Artemis Medicare Services Limited |
|||
|
Price: ₹264.30 (0.65%) | ||
| 52 Week Low: ₹203.35 52 Week High: ₹297.50 |
|||
| Market Capital: N/A (Small-cap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Artemis Medicare Share Price Target For 2026
- 1.1.1: Artemis Medicare Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Artemis Medicare Share Price Target For 2027
- 1.2.1: Artemis Medicare Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Artemis Medicare Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Artemis Medicare Brief Company Overview
Artemis Medicare, a Small Cap company has delivered 768.1% returns in 5-year, making it a potential Multibagger.
To predict the Artemis Medicare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Artemis Medicare Share Price Target For 2026
The line chart displays the monthly closing prices of Artemis Medicare with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Artemis Medicare shares in 2026, see the table below.
Artemis Medicare Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 303.18 (+14.71%) | Volatility: ATR T2 |
| 2026 Target 2 | 287.79 (+8.88%) | Volatility: BB Upper |
| 2026 Target 1 | 287.63 (+8.82%) | Volatility: ATR T1 |
| Current Price | 264.30 | Artemis Medicare's share price as of 15 Jun 2026 |
| Stop Loss 1 | 263.21 (-0.42%) | Trend: EMA9 |
| Stop Loss 2 | 261.53 (-1.05%) | 38.20% Weekly Fib Retrace |
| Stop Loss 3 | 254.35 (-3.77%) | Trend: SMA50 |
Short-Term Technical Outlook
Current Technical Position: Artemis Medicare is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹254.35 serves as the nearest technical reference point.
Historical Returns: 3-month: +20.39% | 6-month: -5.99% | 1-year: +1.37%
Artemis Medicare Share Price Target For 2027
The line chart displays the monthly closing prices of Artemis Medicare with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Artemis Medicare shares in 2027, see the table below.
Artemis Medicare Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 303.18 (+14.71%) | Volatility: ATR T2 |
| 2027 Target 2 | 287.79 (+8.88%) | Volatility: BB Upper |
| 2027 Target 1 | 287.63 (+8.82%) | Volatility: ATR T1 |
| Current Price | 264.30 | Artemis Medicare's share price as of 15 Jun 2026 |
| Stop Loss 1 | 263.21 (-0.42%) | Trend: EMA9 |
| Stop Loss 2 | 261.53 (-1.05%) | 38.20% Weekly Fib Retrace |
| Stop Loss 3 | 254.35 (-3.77%) | Trend: SMA50 |
Long-Term Technical Outlook
52-Week Range Analysis: Artemis Medicare is currently trading at 64.7% of its 52-week range (₹203.35 - ₹297.5).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +1.37% | 3-year: +145.42% | 5-year: +768.1%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Artemis Medicare Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹264.30 | ||
| 2026 | ₹311.08 | +17.699583806281% | ₹315.75 |
| 2027 | ₹400.66 | +28.796451073679% | ₹406.67 |
| 2028 | ₹463.21 | +15.611740627964% | ₹470.16 |
| 2029 | ₹530.57 | +14.542000388593% | ₹538.53 |
| 2030 | ₹620.64 | +16.976082326554% | ₹629.95 |
| 2031 | ₹727.30 | +17.185485949987% | ₹738.21 |
| 2032 | ₹820.36 | +12.795270177368% | ₹832.67 |
| 2033 | ₹932.20 | +13.633039153542% | ₹946.18 |
| 2034 | ₹1,004.33 | +7.7376099549453% | ₹1,019.39 |
| 2035 | ₹1,128.09 | +12.322642956001% | ₹1,145.01 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Artemis Medicare Brief Company Overview
Artemis Medicare Services Limited: A Reputable Healthcare Provider Artemis Medicare Services Limited, established in 2004, is a renowned healthcare company in India and internationally. Key Products and Services: Multi-specialty hospitals, medical and surgical...
treatments, inpatient and outpatient services. Market Presence: Operates Artemis Hospital in Gurugram and has an international presence. Reputation: Recognized for its high-quality healthcare services and commitment to patient well-being. Diverse Product Range: Offers a wide range of services including billing and insurance, child care, health services, and wellness programs. Commitment: Dedicated to providing comprehensive healthcare solutions and promoting healthy living.Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
